These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 11679500

  • 1. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
    Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G, Crosignani PG.
    Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
    [Abstract] [Full Text] [Related]

  • 2. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, Bouchard P, Frydman R.
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 5. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J, De Vits A, Joostens M, Van Royen E.
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [Abstract] [Full Text] [Related]

  • 6. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
    Checa MA, Prat M, Robles A, Carreras R.
    Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
    [Abstract] [Full Text] [Related]

  • 7. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
    Tavaniotou A, Albano C, Smitz J, Devroey P.
    Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
    [Abstract] [Full Text] [Related]

  • 8. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles.
    Albano C, Smitz J, Tournaye H, Riethmüller-Winzen H, Van Steirteghem A, Devroey P.
    Hum Reprod; 1999 Jun; 14(6):1426-30. PubMed ID: 10357952
    [Abstract] [Full Text] [Related]

  • 9. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles.
    Tavaniotou A, Devroey P.
    Reprod Biomed Online; 2006 Sep; 13(3):326-30. PubMed ID: 16984758
    [Abstract] [Full Text] [Related]

  • 10. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 11. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L, Tournaye H, Stoop D, Van Vaerenbergh I, Bourgain C, Polyzos NP, Haentjens P, Blockeel C.
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [Abstract] [Full Text] [Related]

  • 12. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R.
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [Abstract] [Full Text] [Related]

  • 13. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [Abstract] [Full Text] [Related]

  • 14. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
    Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, Devroey P.
    Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
    [Abstract] [Full Text] [Related]

  • 15. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL, Acevedo-Martín B, Chávez M, Manzanares M, Ricciarelli E, Hernández ER.
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages.
    Ragni G, Alagna F, Brigante C, Riccaboni A, Colombo M, Somigliana E, Crosignani PG.
    Hum Reprod; 2004 Jan; 19(1):54-8. PubMed ID: 14688156
    [Abstract] [Full Text] [Related]

  • 18. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM, Lunn SF, Morris KD, Deghenghi R.
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.